Browse by Aston Author

Article

Bailey, Clifford J. (2024). Metformin:Therapeutic profile in the treatment of type 2 diabetes. Diabetes, Obesity and Metabolism, 26 (S3), pp. 3-19.

Bailey, Clifford J, Flatt, Peter R and Conlon, J Michael (2024). Recent advances in peptide-based therapies for obesity and type 2 diabetes. Peptides, 173 ,

Gavin, James R. and Bailey, Clifford j. (2023). Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future. Diabetes Technology & Therapeutics, 25 (S3), S5-S13.

Thomas, Keith G, Klempel, Natalie J, Flatt, Peter R, Bailey, Clifford J and Moffett, R Charlotte (2023). Synthalin::a lost lesson for glucagon suppression in diabetes therapeutics. Journal of Pharmacy and Pharmacology, 75 (6), pp. 758-763.

Bailey, Clifford J, Flatt, Peter R and Conlon, J Michael (2023). An update on peptide-based therapies for type 2 diabetes and obesity. Peptides, 161 ,

De Block, Christophe, Bailey, Clifford, Wysham, Carol, Hemmingway, Andrea, Allen, Sheryl Elaine and Peleshok, Jennifer (2023). Tirzepatide for the treatment of adults with type 2 diabetes: an endocrine perspective. Diabetes, Obesity and Metabolism, 25 (1), pp. 3-17.

Schernthaner, Guntram, Brand, Kerstin and Bailey, Clifford J (2022). Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure. Metabolism: clinical and experimental, 130 ,

Bailey, Clifford J. and Gwilt, Mike (2022). Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin. Frontiers in Pharmacology, 13 ,

Bailey, Clifford J., Day, Caroline and Bellary, Srikanth (2022). Renal Protection with SGLT2 Inhibitors:Effects in Acute and Chronic Kidney Disease. Current Diabetes Reports, 22 (1), pp. 39-52.

Ampong, Isaac, John Ikwuobe, O., Brown, James Ep, Bailey, Clifford J, Gao, Dan, Gutierrez-merino, Jorge and Griffiths, Helen R (2022). Odd chain fatty acid metabolism in mice after a high fat diet. International Journal of Biochemistry and Cell Biology, 143 ,

Conlon, J. Michael, Flatt, Peter R. and Bailey, Clifford J. (2021). Recent advances in peptide-based therapy for Type 2 diabetes and obesity. Peptides, 145 ,

Gavin, James R. and Bailey, Clifford (2021). Real-world studies support use of continuous glucose monitoring in Type 1 and Type 2 diabetes independently of treatment regimen. Diabetes Technology & Therapeutics, 23 (S3), S19-S27.

Murray, Hilary E, Zafar, Ali, Qureshi, Khalid M, Paget, Michelle B, Bailey, Clifford J and Downing, Richard (2021). The potential role of multifunctional human amniotic epithelial cells in pancreatic islet transplantation. Journal of Tissue Engineering and Regenerative Medicine, 15 (7), pp. 599-611.

Bhatt, Deepak L., Szarek, Michael, Pitt, Bertram, Cannon, Christopher P., Leiter, Lawrence A., McGuire, Darren K., Lewis, Julia B., Riddle, Matthew C., Inzucchi, Silvio E., Kosiborod, Mikhail N., Cherney, David Z.I., Dwyer, Jamie P., Scirica, Benjamin M., Bailey, Clifford J., Díaz, Rafael, Ray, Kausik K., Udell, Jacob A., Lopes, Renato D., Lapuerta, Pablo and Gabriel Steg, P. (2021). Sotagliflozin in patients with diabetes and chronic kidney disease. New England Journal of Medicine, 384 (2), pp. 129-139.

Bailey, Clifford J. (2020). GIP analogues and the treatment of obesity-diabetes. Peptides, 125 ,

Lascar, Nadia, Altaf, Quratul-Ain, Raymond, Neil T, Brown, James Ep, Pattison, Helen, Barnett, Anthony, Bailey, Clifford J and Bellary, Srikanth (2019). Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes. Current Medical Research and Opinion, 35 (11), pp. 1893-1900.

Bailey, Clifford J., Del Prato, Stefano, Wei, Cheryl, Reyner, Daniel and Saraiva, Gabriela (2019). Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes. Diabetes, Obesity and Metabolism, 21 (11), pp. 2564-2569.

Bailey, Clifford J. and Day, Caroline (2019). The future of new drugs for diabetes management. Diabetes Research and Clinical Practice, 155 ,

Zafar, Ali, Lee, Jou, Yesmin, Shameema, Paget, Michelle B., Bailey, Clifford J., Murray, Hilary E. and Downing, Richard (2019). Rotational culture and integration with amniotic stem cells reduce porcine islet immunoreactivity in vitro and slow xeno‐rejection in a murine model of islet transplantation. Xenotransplantation, 26 (4),

Bailey, Clifford J (2019). Uric acid and the cardio-renal effects of SGLT2 inhibitors. Diabetes, Obesity and Metabolism, 21 (6), pp. 1291-1298.

Bailey, Clifford J (2019). FDA guidance on cardiovascular risk of antidiabetic therapies: one decade later. Diabetes, Obesity and Metabolism, 21 (5), pp. 1079-1080.

Bailey, Clifford J. (2019). Insulin resistance:Impact on therapeutic developments in diabetes. Diabetes and Vascular Disease Research, 16 (2), pp. 128-132.

Bailey, Clifford J. and Marx, Nikolaus (2019). Cardiovascular protection in type 2 diabetes:Insights from recent outcome trials. Diabetes, Obesity and Metabolism, 21 (1), pp. 3-14.

Bailey, Clifford J (2018). European Medicines Agency: approval of new glucose-lowering medicines for type 2 diabetes. Diabetes, Obesity and Metabolism, 20 (9), pp. 2057-2058.

Bailey, Clifford J and Day, Caroline (2018). Treatment of type 2 diabetes: future approaches. British Medical Bulletin, 126 (1), pp. 123-137.

Jabbour, Serge, Seufert, Jochen, Scheen, Andre, Bailey, Clifford J., Karup, Cathrina and Langkilde, Anna M. (2018). Dapagliflozin in patients with type 2 diabetes mellitus:a pooled analysis of safety data from phase IIb/III clinical trials. Diabetes, Obesity and Metabolism, 20 (3), pp. 620-628.

Bailey, Clifford J. (2018). Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides. Peptides, 100 , pp. 9-17.

Aggarwal, Naresh, Singla, Anuj, Mathieu, Chantal, Montanya, Eduard, Pfeiffer, Andreas F.H., Johnsson, Eva, Zhao, June, Iqbal, Nayyar and Bailey, Clifford (2018). Metformin extended-release versus immediate-release:An international, randomized, double-blind, head-to-head trial in pharmacotherapy-naïve patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 20 (2), pp. 463-467.

Lascar, Nadia, Brown, James, Pattison, Helen, Barnett, Anthony H., Bailey, Clifford J. and Bellary, Srikanth (2018). Type 2 diabetes in adolescents and young adults. The Lancet Diabetes and Endocrinology, 6 (1), pp. 69-80.

Rana, Karan S, Pararasa, Chathyan, Afzal, Islam, Nagel, David A, Hill, Eric J, Bailey, Clifford J, Griffiths, Helen R, Kyrou, Ioannis, Randeva, Harpal S, Bellary, Srikanth and Brown, James E (2017). Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels. Cardiovascular Diabetology, 16 (1),

Bailey, Clifford J. (2017). Metformin:historical overview. Diabetologia, 60 (9), 1566–1576.

Blonde, Lawrence, Aschner, Pablo, Bailey, Clifford, Ji, Linong, Leiter, Lawrence A., Matthaei, Stephan and on behalf of the Global Partnership for Effective Diabetes Manag (2017). Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diabetes and Vascular Disease Research, 14 (3), pp. 172-183.

McGill, Margaret, Blonde, Lawrence, Chan, Juliana C.N., Khunti, Kamlesh, Lavalle, Fernando J. and Bailey, Clifford J. (2017). The interdisciplinary team in type 2 diabetes management:challenges and best practice solutions from real-world scenarios. Journal of Clinical and Translational Endocrinology, 7 , pp. 21-27.

Tahrani, Abd A., Barnett, Anthony H. and Bailey, Clifford J. (2016). Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nature Reviews Endocrinology, 12 (10), 566–592.

Wilding, John, Bailey, Clifford, Rigney, Una, Blak, Betina, Beekman, Wendy and Emmas, Cathy (2016). Glycated hemoglobin, body weight and blood pressure in type 2 diabetes patients initiating dapagliflozin treatment in primary care:a retrospective study. Diabetes Therapy, 7 (4), pp. 695-711.

Bailey, Clifford J., Tahrani, Abd A. and Barnett, Anthony H. (2016). Future glucose-lowering drugs for type 2 diabetes. The Lancet Diabetes and Endocrinology, 4 (4), pp. 350-359.

McCreight, Laura J., Bailey, Clifford J. and Pearson, Ewan R. (2016). Metformin and the gastrointestinal tract. Diabetologia, 59 (3), pp. 426-435.

Pararasa, Chathyan, Ikwuobe, John, Shigdar, Shahjahan, Boukouvalas, Alexis, Nabney, Ian T., Brown, James E., Devitt, Andrew, Bailey, Clifford J., Bennett, Stuart J. and Griffiths, Helen R. (2016). Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell, 15 (1), pp. 128-139.

Pararasa, Chathyan, Bailey, Clifford J. and Griffiths, Helen R. (2015). Ageing, adipose tissue, fatty acids and inflammation. Biogerontology, 16 (2), pp. 235-248.

Fouqueray, Pascale, Pirags, Valdis, Diamant, Michaela, Schernthaner, Guntram, Lebovitz, Harold E., Inzucchi, Silvio E. and Bailey, Clifford J. (2014). The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy. Diabetes Care, 37 (7), pp. 1924-1930.

Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc and Raz, Itamar (2014). Insulin therapy in people with type 2 diabetes:opportunities and challenges? Diabetes Care, 37 (6), pp. 1499-1508.

Rana, Karan S., Arif, Muhammad, Hill, Eric J., Aldred, Sarah, Nagel, David A., Nevill, Alan, Randeva, Harpal S., Bailey, Clifford J., Bellary, Srikanth and Brown, James E. (2014). Plasma irisin levels predict telomere length in healthy adults. Age, 36 (2), pp. 995-1001.

Al-Khattawi, Ali, Iyire, Affiong, Dennison, Tom, Dahmash, Eman, Bailey, Clifford J, Smith, Julian, Rue, Peter and Mohammed, Afzal R. (2014). Systematic screening of compressed ODT excipients : cellulosic versus non-cellulosic. Current drug delivery, 11 , pp. 1-15.

Bailey, Clifford J. (2013). Interpreting adverse signals in diabetes drug development programs. Diabetes Care, 36 (7), pp. 2098-2106.

Fouqueray, Pascale, Pirags, Valdis, Inzucchi, Silvio E., Bailey, Clifford J., Schernthaner, Guntram, Diamant, Michaela and Lebovitz, Harold E. (2013). The efficacy and safety of imeglimin as add-on therapy in patientswith type 2 diabetes inadequately controlled with metformin monotherapy. Diabetes Care, 36 (3), pp. 565-568.

Bailey, Clifford J., Gross, Jorge L., Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A. and List, James F. (2013). Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin:a randomized, double-blind, placebo-controlled 102-week trial. BMC Medicine, 11 (1),

Bailey, Clifford J. (2011). The challenge of managing coexistent type 2 diabetes and obesity. BMJ, 342 (7803),

Del Prato, Stefano, LaSalle, J., Matthaei, S., Bailey, Clifford and Global Partnership for Effective Diabetes Management (2010). Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. International Journal of Clinical Practice, 64 (3), pp. 295-304.

Bailey, Cliff J. (2008). Metformin:a multitasking medication. Diabetes and Vascular Disease Research, 5 (3), p. 156.

Home, P.D., Bailey, C.J., Donaldson, J., Chen, H. and Stewart, M.W. (2007). A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with type 2 diabetes. Diabetic Medicine, 24 (6), pp. 618-625.

Richardson, D.K., Jones, R.B. and Bailey, C.J. (2006). The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice and in isolated human adipocytes. Hormone and Metabolic Research, 38 (11), pp. 727-731.

Irwin, Nigel, Green, Brian D., Gault, Victor A., Greer, Brett, Harriott, Patrick, Bailey, Clifford J., Flatt, Peter R. and O'Harte, Finbarr P.M. (2005). Degradation, insulin secretion, and antihyperglycemic actions of two palmitate-derivitized N-terminal pyroglutamyl analogues of glucose-dependent insulinotropic polypeptide. Journal of Medicinal Chemistry, 48 (4), pp. 1244-1250.

Davies, Emma L., Abdel-Wahab, Yasser H A, Flatt, Peter R. and Bailey, Clifford J. (2001). Functional enhancement of electrofusion-derived BRIN-BD11 insulin-secreting cells after implantation into diabetic mice. International Journal of Experimental Diabetes Research, 2 (1), pp. 29-36.

Thesis

Bailey, Clifford J. (1973). Studies on the influence of sex hormones on glucose tolerance and insulin secretion in the rat. PHD thesis, Aston University.